Fig. 1From: The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled studyFlowchart for the study population. NacA, treatment group; ICU, intensive care unit; RRT, renal replacement therapy; CT, computed tomographyBack to article page